C83.92 Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes

Name of the Condition

• Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes. This falls under the International Classification of Diseases (ICD) code C83.92.

Summary

Non-follicular (diffuse) lymphoma is a type of non-Hodgkin lymphoma characterized by abnormal growth of lymphoid cells that do not form follicular structures. It involves the proliferation of B-cells or T-cells in lymph nodes or other lymphoid tissues, with no specific histologic subtype identified. This code specifies involvement of intrathoracic lymph nodes, which include those in the chest cavity.

Causes

The exact cause of this condition is not well understood but may involve genetic mutations, a weakened immune system, and environmental factors. Certain infections, such as Epstein-Barr virus, can also play a role in the development of lymphomas.

Risk Factors

• Age (more common in older adults)
• Family history of lymphoma
• Exposure to certain chemicals or radiation
• Presence of autoimmune diseases or immunosuppression

Symptoms

• Swollen, painless lymph nodes in the chest area
• Unexplained weight loss
• Fever and night sweats
• Fatigue
• Loss of appetite
• Shortness of breath or cough (if lymph nodes compress nearby structures)

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT or PET scans) to identify affected areas, biopsy of lymph nodes or tissues for laboratory analysis, and blood tests to assess overall health and detect abnormal cell markers. Imaging may focus on the thoracic region to confirm intrathoracic involvement.

Treatment Options

• Chemotherapy to kill cancer cells
• Radiation therapy to target affected lymph nodes
• Immunotherapy to enhance the immune system's response
• Stem cell transplant in advanced cases
• Targeted therapy for specific molecular markers (if identified)

Prognosis and Follow-Up

Prognosis depends on factors such as the extent of disease, patient age, and response to treatment. Regular follow-up with imaging and blood tests is typically recommended to monitor for recurrence or progression. Long-term surveillance may be necessary, especially if the disease is aggressive.

Complications

• Compression of nearby structures (e.g., airways, blood vessels) leading to respiratory symptoms
• Spread of lymphoma to other organs
• Increased risk of infections due to impaired immune function
• Side effects from treatment (e.g., fatigue, nausea, or organ damage)

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise
• Avoid exposure to known carcinogens (e.g., certain chemicals or radiation)
• Manage underlying autoimmune conditions with medical guidance
• Stay up-to-date with vaccinations to reduce infection risk

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or respiratory symptoms (e.g., shortness of breath). Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

When coding for C83.92, ensure the documentation specifies "intrathoracic lymph nodes" to justify the code. Verify that the diagnosis aligns with non-follicular (diffuse) lymphoma and that no more specific subtype or site is documented, as this code is for unspecified intrathoracic involvement. Confirm that the condition is not better classified under a different lymphoma code.